In Figure 4c, we display the differentially expressed genes from these spatial domains and note such results as the over-expression of ERBB2 (HER2), which encodes a member of the epidermal growth factor receptors and would contribute to the development and progression of certain aggressive types of breast cancers. This evidence concerns the gene ERBB2 and breast carcinoma.